The report analyzes and forecasts the Auto-Injectors market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
DOWNLOAD FREE SAMPLE
https://www.acumenresearchandconsulting.com/request-sample/1547
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Auto-Injectors market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
Market Participants
The key players operating in the market include Eli Lilly; Teva Pharmaceutical; Amgen; Pfizer, Inc.; Owen Mumford; Ypsomed; Scandinavian Health Ltd.; AbbVie, Inc.; Biogen Idec; Mylan N.V.; and Sanofi.
Market Segmentation
Global Auto-Injectors Market, by Product Type
Global Auto-Injectors Market, by Disease Indication
Global Auto-Injectors Market, by End-use
Global Auto-Injectors Market, by Geography
Table Of Content
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Auto-Injectors
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Auto-Injectors Market By Product Type
1.2.2.1. Global Auto-Injectors Market Revenue and Growth Rate Comparison By Product Type (2015-2026)
1.2.2.2. Global Auto-Injectors Market Revenue Share By Product Type in 2017
1.2.2.3. Disposable Auto-Injectors
1.2.2.4. Reusable Auto-Injectors
1.2.2.5.1. Prefilled Auto-injectors
1.2.2.5.2. Empty Auto-injectors
1.2.2.6. Others
1.2.3. Auto-Injectors Market By Disease Indication
1.2.3.1. Global Auto-Injectors Market Revenue and Growth Rate Comparison By Disease Indication (2015-2026)
1.2.3.2. Rheumatoid Arthritis
1.2.3.3. Multiple Sclerosis
1.2.3.4. Diabetes
1.2.3.5. Anaphylaxis
1.2.3.6. Other Therapies
1.2.4. Auto-Injectors Market By End Users
1.2.4.1. Global Auto-Injectors Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Home Care Settings
1.2.4.3. Hospitals & Clinics
1.2.4.4. Ambulatory Surgical Centers
1.2.4.5. Others
1.2.5. Auto-Injectors Market by Geography
1.2.5.1. Global Auto-Injectors Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Auto-Injectors Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Auto-Injectors Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Auto-Injectors Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Auto-Injectors Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Auto-Injectors Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Auto-Injectors Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Auto-Injectors Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Auto-Injectors Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Auto-Injectors Major Manufacturers in 2017
CHAPTER 4. AUTO-INJECTORS MARKET BY PRODUCT TYPE
4.1. Global Auto-Injectors Revenue By Product Type
4.2. Disposable Auto-Injectors
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Reusable Auto-Injectors
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3.3. Prefilled Auto-injectors
4.3.4. Empty Auto-injectors
CHAPTER 5. AUTO-INJECTORS MARKET BY DISEASE INDICATION
5.1. Global Auto-Injectors Revenue By Disease Indication
5.2. Rheumatoid Arthritis
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Multiple Sclerosis
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Diabetes
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Anaphylaxis
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.6. Other Therapies
5.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 6. AUTO-INJECTORS MARKET BY END USERS
6.1. Global Auto-Injectors Revenue By End Users
6.2. Home Care Settings
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Hospitals & Clinics
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Ambulatory Surgical Centers
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 7. NORTH AMERICA AUTO-INJECTORS MARKET BY COUNTRY
7.1. North America Auto-Injectors Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America Auto-Injectors Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Auto-Injectors Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Disease Indication, 2015 – 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Disease Indication, 2015 – 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Disease Indication, 2015 – 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
CHAPTER 8. EUROPE AUTO-INJECTORS MARKET BY COUNTRY
8.1. Europe Auto-Injectors Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe Auto-Injectors Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Disease Indication, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Disease Indication, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Disease Indication, 2015 – 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Disease Indication, 2015 – 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Disease Indication, 2015 – 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)
…
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
The report provides size (in terms of volume and value) of Auto-Injectors market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Key Questions Answered in the Report
The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-
The behavioral health market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa…
Key Players & Strategies Key players operating in the market are Acadia Healthcare, The MENTOR Network, Universal Health Services, Inc.,…
Europe hold maximum share for behavioral health market. The global behavioural health market is estimated to grow at a healthy…
The global behavioural health market is estimated to grow at a healthy CAGR of over 2.5% during the forecast period…
The global behavioural health market is estimated to grow at a healthy CAGR of over 2.5% during the forecast period…
The latest survey on global Refractory Market is conducted covering various organizations of the industry from different geographies to come…